Alaska: RSV Workgroup recommend Synagis for qualifying children to start now
by News Desk from Outbreak News Today on (#42QQC)
An Alaska Respiratory Syncytial Virus (RSV) Workgroup of health care providers and public health officials reviewed RSV seasonality data in past years this September and recommended administration of palivizumab (Synagis(R)) to qualifying infants and children during November 28, 2018 through May 22, 2019, to provide the best coverage for RSV prevention in Alaska. The Workgroup ["]
The post Alaska: RSV Workgroup recommend Synagis for qualifying children to start now appeared first on Outbreak News Today.